BSG/RCP joint conference: 'GI Cancer in the UK: Can we do better?'
"GI Cancer in the UK: Can we do better?" will take place at the Royal College of Physicians and is co-badged by the British Society of Gastroenterology (BSG).
BSG members can benefit from a reduced registration fee. Please follow the link below to book your place. Do so early to avoid disappointment. This conference is focused upon gastrointestinal cancer survival in the UK. With published outcomes in this country bearing unfavourable comparison with Europe, this meeting is set to explore the potential for the UK to do better - with the emphasis being very much on prevention and earlier detection. It also follows the recent publication of the Independent Cancer Taskforce's Cancer Strategy for England "Achieving World-Class Cancer Outcomes". The BSG hopes you will be able to attend what promises to be an excellent event with a high calibre programme of speakers.
The conference will provide a forum to cover:
- new pathways to earlier diagnosis
- the primary and secondary interface
- managing demand and capacity in endoscopy
- improving detection.
Chair Academic Development Committee
Commencing: December 2015
We are seeking to appoint a new Chair of the Academic Development Committee. The purpose of the role is to enhance the development of academic activity in gastroenterology and liver disease in the UK. The successful candidate would be expected to establish and chair a small committee of influential academics to promote & enhance academic training & careers for medical students, junior doctors, StRs and consultants. The Chair would be expected to represent this committee at the SAC & BSG Training Committee & Education Committee.
Closing date: 31st October 2015
NICE developing service guidance on the organisation and delivery of diagnostic services
The National Clinical Guideline Centre (NCGC) has been commissioned by NICE to develop service guidance on the organisation and delivery of diagnostic services. The draft guideline scope is currently out for consultation (https://www.nice.org.uk/guidance/indevelopment/gid-cgwave0773).
The NCGC are currently recruiting members for the guideline committee. The advert can be found at https://www.nice.org.uk/get-involved/join-a-committee/member-diagnostic-services-gc, including details of the specific roles they are seeking. Please circulate this information to your colleagues.
The closing date for applications is Monday 2 November 2015 at 5pm. Telephone interviews will be held on Monday 23 November 2015.
Cancer Genetics in Clinical Practice
A Guide to Cancer Genetics in Clinical Practice
BSG member Sue Clark has recently published a new textbook 'A GUIDE TO CANCER GENETICS IN CLINICAL PRACTICE' which has a significant gastroenterology content.
This book covers the basic concepts of cancer genetics. The common inherited cancer syndromes are each dealt with in greater depth, with the current management outlined. It is aimed at all clinicians who may encounter these conditions in their practice. The book sets out to facilitate identification of high-risk individuals and families, to inform interaction with geneticists and other sub-specialists, to provide a basis for patient management and to stimulate interest in these fascinating conditions.
View Flyer / Purchasing Details [ 38 Kb ]
Publication date: June 2009
BSG Guidance on Coeliac Disease 2010
The Management of Adults with Coeliac Disease
There is clear evidence that coeliac disease is a common gastrointestinal disease affecting up to 1% of the adult population. Individuals may go undetected for many years. This is despite multiple presentations to both primary and secondary care. This may reflect that fact that affected individuals have subtle gastrointestinal symptoms or no gastrointestinal symptoms.
An active case finding strategy will increase the number of patients detected with coeliac disease. Testing for coeliac disease should incorporate an IgA level, Tissue Transglutaminase antibody and/or Endomysial antibody (depending on what is locally available). In patients with a positive antibody a duodenal biopsy should be undertaken to confirm the presence of villous atrophy. In patients who are antibody negative but the clinician is suspicious then a duodenal biopsy should still be undertaken having ensured that the patient is not on a self-imposed gluten-free diet (GFD).
The cornerstone of treatment is a GFD. Patients require regular dietetic support with the opportunity or access to a gastroenterologist should further problems arise. Follow-up may be in primary or secondary care as long as the support is adequate (as noted previously).
In patients with persisting symptoms they should be investigated carefully with particular reference to ensuring that refractory coeliac disease is excluded.
Page 4 of 17